Next Article in Journal
Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent
Next Article in Special Issue
Stimulation of Hemolysis and Eryptosis by β-Caryophyllene Oxide
Previous Article in Journal
Analysis of Kinematic and Muscular Fatigue in Long-Distance Swimmers
Previous Article in Special Issue
Therapeutic Potential of Myrtenal and Its Derivatives—A Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Life
Volume 13
Issue 11
10.3390/life13112130
life-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Poria cocos Lanostane Triterpenoids Extract Promotes Collagen and Hyaluronic Acid Production in D-Galactose-Induced Aging Rats

by
Chien-Liang Chao
1,†,
Han-Peng Kuo
2,†,
Hsin-Wen Huang
1,
Maw-Yeun Cheng
1,
Hsin-Fan Chao
1,
Shih-Min Lu
1,
Hang-Ching Lin
1,3,
Chao-Jih Wang
4,
Tsu-Chung Chang
5,* and
Chi-Rei Wu
6,*
1
Sinphar Pharmaceutical Co., Ltd., Sinphar Group, Yilan 269, Taiwan
2
SynCore Biotechnology Co., Ltd., Sinphar Group, Yilan 269, Taiwan
3
School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan
4
Sinphar Tian-Li Pharmaceutical Co., Ltd., Sinphar Group, Hangzhou 311100, China
5
Department of Biochemistry, National Defense Medical Center, Taipei 114, Taiwan
6
Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Life 2023, 13(11), 2130; https://doi.org/10.3390/life13112130
Submission received: 11 September 2023 / Revised: 18 October 2023 / Accepted: 24 October 2023 / Published: 28 October 2023
(This article belongs to the Special Issue Current and Recent Advances in Natural Products-Based Drug Discovery, Design and Development)
Browse Figures
Versions Notes

Abstract

:
The global aging population is expanding at an increasingly rapid pace, with approximately one-fourth of the world’s population expected to be composed of elderly individuals by 2050. Aging skin is one of the major characteristics expressed in the elderly. The study comprehensively utilizes both cell and animal experiments to confirm the skin anti-aging effects of Poria cocos (P. cocos), which is one of the most important traditional Chinese medicines classified as tonic Chinese medicine, commonly used to treat physical weakness and aging-associated diseases. We demonstrate in this study that P. cocos lanostane triterpenoids extract (Lipucan®) ameliorates aging skin and promotes collagen accumulation and hyaluronic acid production in galactose-induced aging rats. Purified lanostane triterpenoids were initially identified as active components in P. cocos, which significantly increased collagen and hyaluronic acid levels in cultured human skin cells.

1. Introduction

Human skin has many physiological functions. The skin is the organ of the body with the largest surface area. Among these many functions, it has a basic role as the body’s first protective barrier to defend against bacteria, virus, chemicals, particulates, solar ultraviolet, and even mechanical injury [1,2,3,4,5]. Because of direct and frequent contact with the exterior environment, the skin usually suffers more damage than most other organs in the body. The skin consists of three main layers, the epidermis, dermis, and hypodermis [5]. The epidermis is the outermost skin layer. The epidermis outer layer is the stratum corneum, which consists of approximately 15–20 layers of keratinocytes and provides most of the effective barrier function [4,5,6,7]. The other epidermis layers are the stratum lucidum (only in the hands and feet), stratum granulosum, stratum spinosum, and stratum basale. The dermis layer has comprehensive elasticity, strength, and moisturizing functions, containing the nervous, lymphatic, and vascular systems and extracellular matrix proteins such as collagen and those for skin moisture such as hyaluronic acid [8]. Collagen is one of the main and most abundant proteins in the human extracellular matrix. It is found in the dermis, ligaments, tendons, vessel walls, and other connective tissues. Collagens are the most abundant proteins in mammals, and they occupy about 70–80% of the dry skin weight and contribute to the dermis structural integrity. The collagen family contains 28 types with one or more triple-helical domains. Among them, types I and III are the major types of collagens in the skin [9,10]. Hyaluronic acid (also known as Hyaluronan, HA) is a glycosaminoglycan with basic structure composed of repeating disaccharide units (D-glucuronic acid and N-acetylglucosamine) [8]. HA is most abundant in the human skin, making up almost 50% of the total body. HA plays a key role closely related to skin moisture because of the strong water retention capacity [8,11,12]. HA in the dermis regulates water balance, osmotic pressure, and ion flow; functions as a sieve to exclude certain molecules and strengthen the cell extracellular domain; and stabilizes skin structures using electrostatic interactions [8]. Skin health is always associated with skin intrinsic (natural) and extrinsic (environmental) aging such as ultraviolet exposure [13]. Both intrinsic and extrinsic aging cause damage to skin function and make a huge change in the skin’s appearance, such as in skin inelasticity, collapse, wrinkles, and dryness. Collagen and HA both play important roles in skin health. The production of collagen and HA continues to decline during human aging [8,13,14]. The elderly population has rapidly increased by nearly threefold from 1950 to 2010 and continues to increase. Skin care has always been one of the most important issues that people care about in the world [15]. Many studies demonstrated that certain natural products and herbal medicines can support collagen and hyaluronic acid production, suggesting their efficacy in fighting against skin aging [16]. For example, a good deal of research indicated that vitamin C (ascorbic acid) increases collagen synthesis, especially type I and type III [17,18]. Camellia japonica oil, Panax ginseng, cinnamon, and Emblica officinalis have all been reported to promote collagen production in human skin cells [19,20,21,22]. Bacillus subtilis natto-fermented Radix astragali enhanced hyaluronic acid production in human skin cells [23]. Despite these studies, there are still many unknown active compounds from natural products that need to be explored and understood to promote skin collagen and hyaluronic acid production.
The dried sclerotium of the saprophytic and edible fungus P. cocos (Schwein) F.A. Wolf (syn. Wolfiporia cocos) in the Polyporaceae family, called Fuling, is one of the most common and important traditional Chinese medicines, belonging to tonic medicine that is widely used in Eastern countries. It has been reported to display wide bioactive effects, including diuretic [24], sedative [25], anti-diabetic [26], immunostimulatory [27,28], anti-inflammatory [29,30], anti-tumor [31], and anti-bacterial [32] activities. The main active constituents of P. cocos are a group of lanostane triterpenoids, which are considered to contribute most of its pharmacological activities [33,34]. This study investigates and explores the potential activities of P. cocos to promote collagen and hyaluronic acid production and the anti-aging activity of P. cocos via in vitro and in vivo studies.

2. Materials and Methods

2.1. Poria cocos Extract Preparation (PCE) (Lipucan®)

The dried sclerotium of P. cocos was extracted using 75% ethanol to obtain P. cocos extract (PCE) (Lipucan®), which was produced by Sinphar Tian-Li Pharmaceutical Co, Ltd., Sinphar Group, Hangzhou, China. The PCE was analyzed by ultra-high-performance liquid chromatography (UPLC, ThermoDionexUltiMate 3000 UHPLC system, Waltham, MA, USA) (Figure 1) and the total content of six lanostane triterpernoid compounds (Figure 2, compounds 1~6) was 21.81%.

2.2. Isolation and Purification of Lanostane Triterpenoid Compounds (1–6)

P. cocos dried sclerotium (10 kg) was extracted three times by refluxing with 75% ethanol for 3 h. The concentrated extract was chromatographed on silica gel (70–230 mesh) using increasingly polar mixtures of CH2Cl2–MeOH (CH2Cl2: MeOH, 97:3; CH2Cl2: MeOH, 96:4; CH2Cl2: MeOH, 90:10; and MeOH only). According to the analytical thin-layer chromatography (TLC), four fractions (Fr.1~Fr.4) were collected for further separation. Fr.1~Fr.3 were subjected to HPLC preparation on a Waters XBridge RP-18 column (250 mm × 19 mm, 5 μm, Milford, MA, USA) using 85% methanol as the mobile phase system. The flow rate was 18 mL/min and six major peaks of interest were selectively collected. The fractions containing the targeted compounds were further condensed to dryness and produced pachymic acid (1) (106 mg), dehydropachymic acid (2) (53 mg), tumulosic acid (3) (120 mg), dehydrotumulosic acid (4) (68 mg), polyporenic acid C (5) (16 mg), and 3-epi-dehydrotumulosic acid (6) (12 mg). Their structures were elucidated using Nuclear Magnetic Resonance (NMR) spectroscopy (Table S1) and electrospray ionization mass (ESI-MS) analyses (Figures S2, S4, S6, S8, S10 and S12) and by comparison with the literature data [35] (Figure 2).

2.3. Animals

Male SD (Sprague Dawley) rats (200–250 g) were obtained from BioLASCO Co., Ltd., Taiwan. They were housed in groups of three, chosen at random, in wire-mesh cages (39 cm × 26 cm × 21 cm) in a temperature- (23 ± 1 °C) and humidity (60%)-regulated environment with a 12 h/12 h light/dark cycle (light phase: 08:00 to 20:00). The Institutional Animal Care and Use Committee of China Medical University approved the experimental protocol (CMUIACUC-2018-243). These animals were cared for according to the Guiding Principles for the Care and Use of Laboratory Animals. After a one-week acclimatization, the rats were randomly grouped according to different doses and used for experiments.

2.4. D-Galactose-Induced Rat Skin Aging Model

Thirty SD rats (10 weeks old) were used in this experiment, randomly divided into five groups of six rats each. The six rats of the normal group were subcutaneously injected (S.C.) with saline for 8 weeks and then orally given distilled water for 4 weeks. The remaining twenty-four rats were designated to the D-galactose-induced skin aging group. The induction procedure was modified using the previous literature [36]. Briefly, rats were treated with D-galactose (100 mg/kg/day, s.c.) in normal saline solution for 8 weeks. D-galactose-induced skin aging rats were then randomly divided into four groups of 6 rats each. The six rats of the D-galactose-induced skin aging group (control group) were orally treated with distilled water daily for 4 weeks after 8 weeks of D-galactose treatment. The remaining eighteen rats were designated to the PCE treatment groups. These groups were divided into PCE-L, PCE-M, and PCE-H groups, in which the rats were orally given either PCE-L (1 mg/kg), PCE-M (3 mg/kg), or PCE-H (6 mg/kg) after 8 weeks of D-galactose treatment. After 4 weeks of distilled water or PCE administration, all rats were sacrificed to collect skin tissues from the rat’s back. The rat’s left back skin tissues were used for hematoxylin and eosin (HE) or immunohistochemical (IHC) staining. The skin tissues from the rat’s right back were used for assaying type I collagen protein expression and the hyaluronic acid content.

2.5. Immunohistochemical (IHC) Staining Procedure

The rat left back skin tissues were cut into 1 cm2 pieces and fixed in 10% formalin. Post-fixation, paraffin slices were prepared and cut into sections (10 μm) using a microtome (Leica Biocut 2030, USA). The paraffin was removed from some skin sections, rehydrated using conventional histological techniques, and then stained with HE (Leica Biosystems, Nussloch GmbH-Nuβloch, Nußloch, Germany) for a morphological assessment. Some sections were incubated with a mouse anti-collagen I monoclonal antibody (Abcam plc; Cambridge, UK) at 4 °C. Subsequently, the histological sections were incubated with anti-mouse biotinylated secondary antibody and the immunohistochemistry reaction was amplified using an avidin–biotin–peroxidase reagent using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA, USA). Digital pictures were taken using 10× objectives (Nikon, Tokyo, Japan). Results were expressed as the average intensity of the positive immunoreactive cells of type I collagen immunohistochemistry (positive pixels)/the full area captured (total pixels) using the image processing and analysis software Java 7 (Windows version, National Institutes of Health, Bethesda, MD, USA).

2.6. Western Blot Analysis of Type I Collagen In Vivo

The skin tissue supernatants were subjected to Western blot analyses to determinate the type I collagen protein expression. The protein concentration was quantified using a Bradford protein assay kit (Bio-Rad, Hercules, CA, USA) followed by electrophoretic separation through SDS-PAGE. After transferring the protein samples to PVDF membranes, the samples were blocked with 5% non-fat dry milk and 0.1% tween-20 in tris-buffered saline at room temperature for 1 h. The membranes were then incubated with primary antibodies against type I collagen (Santa Cruz Biotechnology, Dallas, TX, USA) overnight at 4 °C and subsequently incubated with horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse IgG. Signals were visualized by an enhanced chemiluminescence detection kit (Thermo Fisher Scientific Inc., Waltham, MA, USA) and a LAS-4000 mini-imaging system (Fujifilm, Kanagawa, Japan), and the optical density data were analyzed using MultiGauge v3.0 software (Fujifilm, Kanagawa, Japan). For the Western blot analyses, β-actin (Proteintech, Rosemont, IL, USA) served as an internal control.

2.7. Hyaluronic Acid Measurement In Vivo

The hyaluronic acid quantitative measurement in the rat’s right back skin was carried out in accordance with the manufacturer’s protocols [37]. Briefly, the skin tissues were washed with ice-cold PBS (10 μM, pH = 7.4) to remove excess hemolysis blood thoroughly and were then minced to small pieces. One gram of tissue was homogenized in 9 vol ice-cold PBS (containing a protease inhibitor solution (0.4 M NaCl, 0.05% Tween 20, 0.5% bovine serum albumin, 0.1 mM phenylmethylsulfonylfluoride, 0.1 mM benzethonium chloride, 10 mM EDTA, 10 μg/mL aprotinin)) with an ultrasonic cell disrupter on ice. The homogenates were then centrifuged at 12,000 rpm for 5 min at 4 °C to retrieve the supernatant. The supernatants were then analyzed for the hyaluronic acid content using an enzyme-linked immunosorbent assay (ELISA) kit (Bioscience Inc., San Diego, CA, USA).

2.8. Lanostane Triterpenoid Compounds (1–6) for Collagen and Hyaluronic Acid Analysis in Primary Human Dermal Fibroblasts

Primary human dermal fibroblasts (HDFs) (ATCC) were cultured in fibroblast basal medium supplemented with a serum-free fibroblast growth kit in a water-saturated atmosphere with 5% CO2 at 37 °C. The experiments were conducted 24 h after the cells had been seeded in 6-well (2 × 105 cells/well) sterile clear-bottom plates. Various doses of lanostane triterpenoids (1–6) of P. cocos were dissolved in the culture medium and incubated for 48 h in HDF cells. The culture medium was then collected and concentrated. Equal amounts of proteins from each sample were analyzed for the collagen and hyaluronic acid levels. For the type I collagen level, Western blotting analysis was performed using primary antibodies against type I collagen (Santa Cruz, CA, USA) and β-actin (Arigo, Shanghai, China), and signals were detected using enhanced chemiluminescence kits (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK). The hyaluronic acid production was assessed using an enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer’s protocol (Echelon Bioscience, Salt Lake, UT, USA).

2.9. Statistical Analysis

All data are shown as mean ± standard error of the mean (SEM). Statistically significant differences among groups were analyzed using one-way analysis of variance (ANOVA) (SigmaPlot 11.0 program). Different values between experimental and control groups were statistically significant at p < 0.05.

3. Results

3.1. The Anti-Aging Activity of PCE in D-Galatose-Induced Skin Aging Rats

The skin is characterized using a multi-layered structure consisting of the epidermis and dermis. Skin aging histological features include reduced epidermal thickness, flattening of the dermis and epidermis junction, also known as papillary ridge, and altered dermal structure [38]. The papillary ridges of D-galactose-induced skin aging rats (control group) became flattened (Figure 3A). PCE visibly improves skin flattening induced by D-galactose in a dose-dependent manner. The PCE-H papillary ridge apparently returned to its normal protruding appearance (Figure 3A). In addition, PCE protects the epidermis from thickness reduction due to skin aging (Figure 3B). After the total skin width measurement, PCE increased skin thickness in the D-galactose-induced skin aging group (Figure 3C).

3.2. PCE Promoted Collagen Type I Production in D-Galactose-Induced Skin Aging Rats

To assess the PCE effect in rats with D-galactose-induced skin aging, the type I collagen protein expression in skin tissue was analyzed using Western blot analysis. The result shown in Figure 4 indicated that the type I collagen protein expression in galactose-induced skin aging rat skin tissue decreased to 69.12% compared with that in normal rat skin tissue (p < 0.01). We found that PCE-H significantly promoted type I collagen skin tissue protein expression in D-galactose-induced skin aging rats.

3.3. PCE Promoted Hyaluronic Acid Production in D-Galactose-Induced Skin Aging Rats

To assess the PCE effect in D-galactose-induced skin aging rats, the hyaluronic acid level in skin tissue was also analyzed using ELISA analysis. The results shown in Figure 5 indicated that the skin tissue hyaluronic acid level in D-galactose-induced skin aging rats decreased to 50.84% compared with that of skin tissue in the normal rats (p < 0.001). We found that PCE-M and PCE-H both significantly promoted hyaluronic acid production of skin tissue in D-galactose-induced skin aging rats.

3.4. Isolation and Identification of Six Lanostane Triterpenoid Compounds 1–6 of P. cocos

Dried P. cocos (10 kg) was extracted three times by refluxing with 75% ethanol for 3 h. The concentrated extract was chromatographed on silica gel and a C18 column to furnish six major lanostane triterpenoid compounds: pachymic acid (1) (106 mg), dehydropachymic acid (2) (53 mg), tumulosic acid (3) (120 mg), dehydrotumulosic acid (4) (68 mg), polyporenic acid C (5) (16 mg), and 3-epi-dehydrotumulosic acid (6) (12 mg) (Figure 2). Their structures were elucidated using NMR spectroscopy (Table S1) and ESI-MS analysis (Figures S2, S4, S6, S8, S10 and S12) and comparison with the literature data [32,33]. The UPLC chromatograms of 1–6 are shown in Figures S1, S3, S5, S7, S9 and S11.

3.5. The Effects of Lanostane Triterpenoid Compounds 1–6 of P. cocos on Type I Collagen and Hyaluronic Acid Production in HDF Cells

To identify the identified P. cocos lanostane triterpenoid compounds’ effects, we evaluated the effect of compounds 1–6 on the type I collagen protein expression and hyaluronic acid production in HDF cells. HDF cells were pre-incubated with the above-mentioned compounds for 48 h. From the results shown in Figure 6, 1 μM of lanostane triterpenoid compounds (1), (2), (3), (4), and (5) enhanced the expression of type I collagen (2.11 ± 0.24, 1.22 ± 0.09, 1.47 ± 0.21, 1.27 ± 0.21, and 2.00 ± 0.42-fold with respect to the control sample, with p < 0.01, p < 0.05, p < 0.05, p < 0.05, and p < 0.05, respectively). An amount of 0.1 μM of lanostane triterpenoid compounds (1), (2), (3), (4), and (5) enhanced the expression of type I collagen (2.35 ± 0.07, 1.88 ± 0.16, 1.27 ± 0.1, 1.56 ± 0.05, and 1.82 ± 0.37-fold with respect to the control sample, with p < 0.001, p < 0.01, p < 0.05, p < 0.001, and p < 0.05, respectively). An amount of 0.01 μM of lanostane triterpenoid compounds (1), (2), (3), and (4) enhanced the type I collagen expression (1.27 ± 0.22, 1.54 ± 0.08, 1.48 ± 0.22, and 1.59 ± 0.1-fold with respect to the control sample, with p < 0.01, p < 0.001, p < 0.05, and p < 0.001, respectively). These results indicated that these compounds significantly enhanced the type I collagen protein expression in HDF cells. In addition to its promoting effect on the type I collagen protein expression, the effects of compounds (1)–(6) on hyaluronic acid production were also assessed. The results shown in Figure 7 indicated a significant increase in hyaluronic acid in HDF cells at 1μM of (2), 0.1 μM of (1) and (2), and 0.01 μM of (4) by 151.69%, 131,53%, 131.05%, and 112.41% (p < 0.05, p < 0.05, p < 0.05, and p < 0.05, respectively) compared to the control cells.

4. Discussion

The prolongation of human life span around the world has led to a dramatic increase in the number of elderly people. By 2050, one-sixth of the world’s population will be over the age of 65 [39]. Aging is one of the most important issues in modern society as it can seriously affect the socio-economic and health cost burden. Anti-aging has always been an important research topic. Maintaining a healthy elderly population is an important issue that needs to be handled carefully. With the increase in age, the skin epidermis thickness increases and the collagen and hyaluronic acid contents in the dermis are significantly reduced. P. cocos has been traditionally used with a long history and was first recorded in “Shen Nong’s Materia Medica” [40]. It was classified as a tonic supplement and was believed to prolong human life. At present, there is little in-depth research on P. cocos’s anti-aging effects and the exploration of active compounds in P. cocos. Therefore, the anti-aging activities of P. cocos in skin were investigated and the active ingredients were elucidated in this study. The skin is the largest organ of the human body. It protects the human body from direct environmental influences [2]. It is the reason that skin health is so important for humans. People are willing to use healthy food or cosmetics with functional ingredients to improve skin aging and maintain a good skin condition. Physiologically, skin aging shows thinning of the epidermis, decreased collagen production in the dermis, and reduced skin elasticity. The decrease in hyaluronic acid reduces moisturizing ability and skin stretching, resulting in the loss of protective function and wound healing. Previous studies indicated that mice treated with D-galactose are generally considered to be an ideal animal model for studying oxidative damage and skin aging and P. cocos can effectively alleviate oxidative stress-related skin aging [41,42]. We showed in this study that PCE obviously recovered the skin tissue aging induced by D-galactose in a dose-dependent manner. Aging-induced flattening of papillary ridges in the dermis was induced by D-galactose but PCE restored the normal papillary ridge protrusion structure. In addition, PCE obviously increased skin epidermis and skin width in a dose-dependent manner. Furthermore, the protein expression of type I collagen and the hyaluronic acid in the skin tissues of rats were analyzed to clarify the basis of anti-aging by PCE. In this study, we proved that PCE remarkedly promoted the protein expression of type I collagen and the hyaluronic acid contents in the skin tissue of D-galactose-induced skin aging rats. These results suggest that PCE may increase type I collagen and hyaluronic acid to restore the papillary ridge wavy structure in D-galactose-induced aging rats. Previous reports indicated that lanostane triterpenoids were considered to be the major compounds in the ethyl acetate fraction based on HPLC analysis [28]. But, it remains unclear whether lanostane triterpenoids are active ingredients in skin anti-aging activity. We isolated, purified, and identified six lanostane triterpenoids from P. cocos and investigated their effects on type I collagen protein expression and the hyaluronic acid content in the HDF cell model. We showed that lanostane triterpenoid compounds (1–4) significantly enhanced the type I collagen expression in HDF cells. In addition, we also found that lanostane triterpenoid compounds (1), (2), and (4) significantly increased the hyaluronic acid level in HDF cells. Thus, these lanostane triterpenoid compounds might play a beneficial role in promoting the protein expression of type I collagen and the production of hyaluronic acid, which could be deeply related to strategies for ameliorating skin aging. In the future, further research will be conducted to explore the antioxidative mechanisms of P. cocos and its relationship with the promotion of collagen and hyaluronic acid production.

5. Conclusions

This study is the first to demonstrate the anti-aging action of PCE and its lanostane triterpenoid components on skin aging. PCE obviously recovered skin tissue aging induced by D-galactose in a dose-dependent manner. PCE promoted the protein expression of type I collagen and the production of hyaluronic acid to restore the dermis papillary ridge wavy structure in D-galactose-induced skin aging rats. Further evidence from cell experiments showed that the identified active PCE ingredients enhance type I collagen protein expression and hyaluronic acid production. Our findings support the lanostane triterpenoid components of P. cocos as promising candidates for development into improved therapies for skin aging. The antioxidant mechanism of P. cocos and its relationship with the promotion of collagen and hyaluronic acid production require further research. PCE and its proven active ingredients can be used to develop cosmetics or food supplements.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/life13112130/s1, Table S1. 1H NMR (400 MHz) and 13C (100 MHz) Spectroscopic Data for 1–6. Figure S1. The UPLC chromatogram of pachymic acid (1). Figure S2. The ESI-MS spectrum of pachymic acid (1). Figure S3. The UPLC chromatogram of dehydropachymic acid (2). Figure S4. The ESI-MS spectrum of dehydropachymic acid (2). Figure S5. The UPLC chromatogram of tumulosic acid (3). Figure S6. The ESI-MS spectrum of tumulosic acid (3). Figure S7. The UPLC chromatogram of dehydrotumulosic acid (4). Figure S8. The ESI-MS spectrum of dehydrotumulosic acid (4). Figure S9. The UPLC spectrum of polyporenic acid C (5). Figure S10. The ESI-MS spectrum of polyporenic acid C (5). Figure S11. The UPLC spectrum of 3-Epi-dehydrotumulosic acid (6). Figure S12. The ESI-MS spectrum of 3-Epi-dehydrotumulosic acid (6).

Author Contributions

Conceptualization, H.-C.L., T.-C.C. and C.-R.W.; methodology, T.-C.C. and C.-R.W.; formal analysis, H.-W.H., H.-P.K., M.-Y.C., H.-F.C. and S.-M.L.; investigation, C.-L.C., M.-Y.C., H.-F.C., S.-M.L. and C.-J.W.; writing—original draft preparation, C.-L.C. and H.-W.H.; writing—review and editing, H.-P.K., H.-C.L., C.-J.W., T.-C.C. and C.-R.W. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the Ministry of National Defense (MAB-109-055, MND-MAB-110-118 to T.-C.C.), Taipei, Taiwan.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding authors. The data are not publicly available.

Acknowledgments

We are grateful to Sinphar Pharmaceutical group for providing the commercial natural product (P. cocos extract (Lipucan®)).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mosteller, R.D. Simplified calculation of body-surface area. N. Engl. J. Med. 1987, 317, 1098. [Google Scholar] [PubMed]
  2. Kammeyer, A.; Luiten, R.M. Oxidation events and skin aging. Ageing Res. Rev. 2015, 21, 16–29. [Google Scholar] [CrossRef]
  3. Madison, K.C. Barrier function of the skin: “la raison d’être” of the epidermis. J. Investig. Dermatol. 2003, 121, 231–241. [Google Scholar] [CrossRef]
  4. Del Rosso, J.Q.; Levin, J. The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J. Clin. Aesthet. Dermatol. 2011, 4, 22–42. [Google Scholar]
  5. Arda, O.; Göksügür, N.; Tüzün, Y. Basic histological structure and functions of facial skin. Clin. Dermatol. 2014, 32, 3–13. [Google Scholar] [CrossRef]
  6. Proksch, E.; Brandner, J.M.; Jensen, J.M. The skin: An indispensable barrier. Exp. Dermatol. 2008, 17, 1063–1072. [Google Scholar] [CrossRef] [PubMed]
  7. Menon, G.K.; Cleary, G.W.; Lane, M.E. The structure and function of the stratum corneum. Int. J. Pharm. 2012, 435, 3–9. [Google Scholar] [CrossRef]
  8. Papakonstantinou, E.; Roth, M.; Karakiulakis, G. Hyaluronic acid: A key molecule in skin aging. Dermato-endocrinology 2012, 4, 253–258. [Google Scholar] [CrossRef] [PubMed]
  9. Tzaphlidou, M. The role of collagen and elastin in aged skin: An image processing approach. Micron 2004, 35, 173–177. [Google Scholar] [CrossRef]
  10. Ricard-Blum, S. The collagen family. Cold Spring Harb. Perspect Biol. 2011, 3, a004978. [Google Scholar] [CrossRef]
  11. Juhlin, L. Hyaluronan in skin. J. Intern. Med. 1997, 242, 61–66. [Google Scholar] [CrossRef]
  12. Reed, R.K.; Lilja, K.; Laurent, T.C. Hyaluronan in the rat with special reference to the skin. Acta Physiol. Scand. 1988, 134, 405–411. [Google Scholar] [CrossRef] [PubMed]
  13. Blume-Peytavi, U.; Kottner, J.; Sterry, W.; Hodin, M.W.; Griffiths, T.W.; Watson, R.E.; Hay, R.J.; Griffiths, C.E. Age-associated skin conditions and diseases: Current perspectives and future options. Gerontologist 2016, 56, S230–S242. [Google Scholar] [CrossRef] [PubMed]
  14. Varani, J.; Dame, M.K.; Rittie, L.; Fligiel, S.E.G.; Kang, S.; Fisher, G.J.; Voorhees, J.J. Decreased collagen production in chronologically aged skin: Roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Amer. J. Pathol. 2006, 168, 1861–1868. [Google Scholar] [CrossRef]
  15. Fuster, V. Changing demographics: A new approach to global health care due to the aging population. J. Am. Coll. Cardiol. 2017, 69, 3002–3005. [Google Scholar] [CrossRef] [PubMed]
  16. Binic, I.; Lazarevic, V.; Ljubenovic, M.; Mojsa, J.; Sokolovic, D. Skin ageing: Natural weapons and strategies. Evid. Based. Complement. Alternat. Med. 2013, 2013, 827248. [Google Scholar] [CrossRef] [PubMed]
  17. Pullar, J.M.; Carr, A.C.; Vissers, M.C.M. The roles of vitamin C in skin health. Nutrients 2017, 9, 866. [Google Scholar] [CrossRef]
  18. Nusgens, B.V.; Colige, A.C.; Lambert, C.A.; Lapière, C.M.; Humbert, P.; Rougier, A.; Haftek, M.; Richard, A.; Creidi, P. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J. Investig. Dermatol. 2001, 116, 853–859. [Google Scholar] [CrossRef]
  19. Jung, E.; Lee, J.; Baek, J.; Jung, K.; Lee, J.; Huh, S.; Kim, S.; Koh, J.; Park, D. Effect of camellia japonica oil on human type I procollagen production and skin barrier function. J. Ethnopharmacol. 2007, 112, 127–131. [Google Scholar] [CrossRef]
  20. Lee, J.; Jung, E.; Lee, J.; Huh, S.; Kim, J.; Park, M.; So, J.; Ham, Y.; Jung, K.; Hyun, C.G.; et al. Panax ginseng induces human type I collagen synthesis through activation of Smad signaling. J. Ethnopharmacol. 2007, 109, 29–34. [Google Scholar] [CrossRef]
  21. Takasao, N.; Tsuji-Naito, K.; Ishikura, S.; Tamura, A.; Akagawa, M. Cinnamon extract promotes type I collagen biosynthesis via activation of IGF-I signaling in human dermal fibroblasts. J. Agric. Food Chem. 2012, 60, 1193–1200. [Google Scholar] [CrossRef] [PubMed]
  22. Fujii, T.; Wakaizumi, M.; Ikami, T.; Saito, M. Amla (Emblica officinalis Gaertn.) extract promotes procollagen production and inhibits matrix metalloproteinase-1 in human skin fibroblasts. J. Ethnopharmacol. 2008, 119, 53–57. [Google Scholar] [CrossRef] [PubMed]
  23. Hsu, M.F.; Chiang, B.H. Stimulating effects of Bacillus subtilis natto-fermented radix astragali on hyaluronic acid production in human skin cells. J. Ethnopharmacol. 2009, 125, 474–481. [Google Scholar] [CrossRef] [PubMed]
  24. Giner-Larza, E.M.; Máñez, S.; Giner-Pons, R.M.; Carmen Recio, M.; Rĺos, J.L. On the anti-inflammatory and anti-phospholipase A2 activity of extracts from lanostane-rich species. J. Ethnopharmacol. 2000, 73, 61–69. [Google Scholar] [CrossRef]
  25. Shah, V.K.; Choi, J.J.; Han, J.Y.; Lee, M.K.; Hong, J.T.; Oh, K.W. Pachymic acid enhances pentobarbital-induced sleeping behaviors via GABAA-ergic systems in mice. Biomol. Ther. 2014, 22, 314–320. [Google Scholar] [CrossRef]
  26. Huang, Y.C.; Chang, W.L.; Huang, S.F.; Lin, C.Y.; Lin, H.C.; Chang, T.C. Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur. J. Pharmacol. 2010, 648, 39–49. [Google Scholar] [CrossRef]
  27. Yu, S.J.; Tseng, J. Fu-ling, a chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int. J. Immunopharmacol. 1996, 18, 37–44. [Google Scholar] [CrossRef]
  28. Deqiang, D.; Hang, X.; Xiaofei, W.; Bingyou, Y.; Haixue, K. Immunoenhancing constituents of Poria cocos. Int. J. Pharmacol. 2015, 11, 463–469. [Google Scholar]
  29. Cuellar, M.J.; Giner, R.M.; Recio, M.C.; Just, M.J.; Manez, S.; Rios, J.L. Effect of the basidiomycete Poria cocos on experimental dermatitis and other inflammatory conditions. Chem. Pharm. Bull. 1997, 45, 492–494. [Google Scholar] [CrossRef]
  30. Jeong, J.W.; Lee, H.H.; Han, M.H.; Kim, G.Y.; Hong, S.H.; Park, C.; Choi, Y.H. Ethanol extract of Poria cocos reduces the production of inflammatory mediators by suppressing the NF-kappaB signaling pathway in lipopolysaccharide-stimulated RAW 264.7 macrophages. BMC Complement. Altern. Med. 2014, 14, 101. [Google Scholar] [CrossRef]
  31. Chu, B.F.; Lin, H.C.; Huang, X.W.; Huang, H.Y.; Wu, C.P.; Kao, M.C. An ethanol extract of Poria cocos inhibits the proliferation of non-small cell lung cancer A549 cells via the mitochondria-mediated caspase activation pathway. J. Funct. Foods 2016, 23, 614–627. [Google Scholar] [CrossRef]
  32. Zhang, L.; Ravipati, A.S.; Koyyalamudi, S.R.; Jeong, S.C.; Reddy, N.; Bartlett, J.; Smith, P.T.; de la Cruz, M.; Monteiro, M.C.; Melguizo, Á.; et al. Anti-fungal and anti-bacterial activities of ethanol extracts of selected traditional chinese medicinal herbs. Asian Pac. J. Trop. Med. 2013, 6, 673–681. [Google Scholar] [CrossRef] [PubMed]
  33. Yang, P.F.; Hua, T.; Wang, D.; Zhao, Z.W.; Xi, G.L.; Chen, Z.F. Phytochemical and chemotaxonomic study of Poria cocos (Schw.). Wolf Biochem. Syst. Ecol. 2019, 83, 54–56. [Google Scholar] [CrossRef]
  34. Ding, G.; Wang, Z.Z.; Zhang, C.F.; Sheng, L.S. Study on HPLC fingerprint of the triterpene acids in Poria cocos. Zhongguo Zhong Yao Za Zhi 2002, 27, 756–758. [Google Scholar]
  35. Yang, H.; Shen, Y.; Chen, B.; Jia, X.; Cai, B. RP-HPLC-DAD determination of six triterpenes in a herbal tonic hoelen. J. Liq. Chromatogr. Relat. 2011, 34, 1772–1782. [Google Scholar] [CrossRef]
  36. Chen, P.; Chen, F.; Zhou, B. Antioxidative, anti-inflammatory and anti-apoptotic effects of ellagic acid in liver and brain of rats treated by D-galactose. Sci. Rep. 2018, 8, 1465. [Google Scholar] [CrossRef]
  37. Kim, S.; Kang, B.Y.; Cho, S.Y.; Sung, D.S.; Chang, H.K.; Yeom, M.H.; Kim, D.H.; Sim, Y.C.; Lee, Y.S. Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin. Biochem. Biophys. Res. Commun. 2004, 316, 348–355. [Google Scholar] [CrossRef]
  38. Lynch, B.; Pageon, H.; Le Blay, H.; Brizion, S.; Bastien, P.; Bornschlögl, T.; Domanov, Y. A mechanistic view on the aging human skin through ex vivo layer-by-layer analysis of mechanics and microstructure of facial and mammary dermis. Sci. Rep. 2022, 12, 849. [Google Scholar] [CrossRef]
  39. Nations, U.; Economic, D.; Affairs, S. World Population Prospects 2019; United Nations: New York, NY, USA, 2019. [Google Scholar]
  40. Lu, J.; Tian, J.; Zhou, L.; Meng, L.; Chen, S.; Ma, C.; Wang, J.; Liu, Z.; Li, C.; Kang, W. Phytochemistry and biological activities of Poria. J. Chem. 2021, 2021, 6659775. [Google Scholar] [CrossRef]
  41. Shen, L.H.; Fan, L.; Zhang, Y.; Shen, Y.; Su, Z.T.; Peng, G.N.; Deng, J.L.; Zhong, Z.J.; Wu, X.F.; Yu, S.M.; et al. Antioxidant Capacity and Protective Effect of Cow Placenta Extract on D-Galactose-Induced Skin Aging in Mice. Nutrients 2022, 14, 4659. [Google Scholar] [CrossRef]
  42. Fang, C.L.; Paul, C.R.; Day, C.H.; Chang, R.L.; Kuo, C.H.; Ho, T.J.; Hsieh, D.J.; Viswanadha, V.P.; Kuo, W.W.; Huang, C.Y. Poria cocos (Fuling) targets TGFβ/Smad7 associated collagen accumulation and enhances Nrf2-antioxidant mechanism to exert anti-skin aging effects in human dermal fibroblasts. Environ. Toxicol. 2021, 36, 729–736. [Google Scholar] [CrossRef] [PubMed]
Life 13 02130 g001
Figure 1. The UPLC chromatography of PCE.
Figure 1. The UPLC chromatography of PCE.
Life 13 02130 g001
Life 13 02130 g002
Figure 2. The chemical structures of lanostane triterpenoids 1–6 isolated from P. cocos. 1: pachymic acid; 2: dehydropachymic acid; 3: tumulosic acid; 4: dehydrotumulosic acid; 5: polyporenic acid; 6: 3-epi-dehydrotumulosic acid.
Figure 2. The chemical structures of lanostane triterpenoids 1–6 isolated from P. cocos. 1: pachymic acid; 2: dehydropachymic acid; 3: tumulosic acid; 4: dehydrotumulosic acid; 5: polyporenic acid; 6: 3-epi-dehydrotumulosic acid.
Life 13 02130 g002
Life 13 02130 g003
Figure 3. PCE-L (1 mg/kg), PCE-M (3 mg/kg), and PCE-H (6 mg/kg) effects on skin in D-galactose-induced skin aging rats: (A) skin papillary ridge; (B) skin epidermis thickness; (C) skin width. Columns indicate mean ± SEM (n = 6). * p < 0.05, *** p < 0.001 compared with control group.
Figure 3. PCE-L (1 mg/kg), PCE-M (3 mg/kg), and PCE-H (6 mg/kg) effects on skin in D-galactose-induced skin aging rats: (A) skin papillary ridge; (B) skin epidermis thickness; (C) skin width. Columns indicate mean ± SEM (n = 6). * p < 0.05, *** p < 0.001 compared with control group.
Life 13 02130 g003
Life 13 02130 g004
Figure 4. PCE-L (1 mg/kg), PCE-M (3 mg/kg), and PCE-H (6 mg/kg) effects on skin type I collagen in D-galactose-induced skin aging rats. (A) Western blotting analysis; (B) quantitative analysis shows that PCE-H significantly promoted type I collagen expression in D-galactose-induced skin aging rats. Columns indicate mean ± SEM (n = 6). ** p < 0.01 compared with control group.
Figure 4. PCE-L (1 mg/kg), PCE-M (3 mg/kg), and PCE-H (6 mg/kg) effects on skin type I collagen in D-galactose-induced skin aging rats. (A) Western blotting analysis; (B) quantitative analysis shows that PCE-H significantly promoted type I collagen expression in D-galactose-induced skin aging rats. Columns indicate mean ± SEM (n = 6). ** p < 0.01 compared with control group.
Life 13 02130 g004
Life 13 02130 g005
Figure 5. PCE-L (1 mg/kg), PCE-M (3 mg/kg), and PCE-H (6 mg/kg) effects on hyaluronic acid of skin tissue in D-galactose-induced skin aging rats using ELISA analysis. PCE-M and PCE-H significantly promoted hyaluronic acid production of skin tissue in D-galactose-induced aging rats. Columns indicate mean ± SEM (n = 6). *** p < 0.001 compared with control group.
Figure 5. PCE-L (1 mg/kg), PCE-M (3 mg/kg), and PCE-H (6 mg/kg) effects on hyaluronic acid of skin tissue in D-galactose-induced skin aging rats using ELISA analysis. PCE-M and PCE-H significantly promoted hyaluronic acid production of skin tissue in D-galactose-induced aging rats. Columns indicate mean ± SEM (n = 6). *** p < 0.001 compared with control group.
Life 13 02130 g005
Life 13 02130 g006
Figure 6. Effect of lanostane triterpenoid compounds (1–6) of P. cocos on the protein expression of type I collagen in HDF cells. The cells were incubated with or without the indicated concentrations of each compound for 24 h. (A) The relative expression level of type I collagen in HDF cells (B) quantified using the ImageJ Gel Analysis program (https://imagej.nih.gov/ij/download.html) The relative amount of type I collagen was calculated in HDF cells. Data are presented as the mean ± SD (n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001).
Figure 6. Effect of lanostane triterpenoid compounds (1–6) of P. cocos on the protein expression of type I collagen in HDF cells. The cells were incubated with or without the indicated concentrations of each compound for 24 h. (A) The relative expression level of type I collagen in HDF cells (B) quantified using the ImageJ Gel Analysis program (https://imagej.nih.gov/ij/download.html) The relative amount of type I collagen was calculated in HDF cells. Data are presented as the mean ± SD (n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001).
Life 13 02130 g006
Life 13 02130 g007
Figure 7. Effect of lanostane triterpenoid compounds (1–6) of P. cocos on hyaluronic acid level in HDF cells. The cells were incubated with or without the indicated concentrations of each compound for 24 h. The relative amount of hyaluronic acid produced in HDF cells. Data are presented as the mean ± SD (n = 3; * p < 0.05).
Figure 7. Effect of lanostane triterpenoid compounds (1–6) of P. cocos on hyaluronic acid level in HDF cells. The cells were incubated with or without the indicated concentrations of each compound for 24 h. The relative amount of hyaluronic acid produced in HDF cells. Data are presented as the mean ± SD (n = 3; * p < 0.05).
Life 13 02130 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chao, C.-L.; Kuo, H.-P.; Huang, H.-W.; Cheng, M.-Y.; Chao, H.-F.; Lu, S.-M.; Lin, H.-C.; Wang, C.-J.; Chang, T.-C.; Wu, C.-R. Poria cocos Lanostane Triterpenoids Extract Promotes Collagen and Hyaluronic Acid Production in D-Galactose-Induced Aging Rats. Life 2023, 13, 2130. https://doi.org/10.3390/life13112130

AMA Style

Chao C-L, Kuo H-P, Huang H-W, Cheng M-Y, Chao H-F, Lu S-M, Lin H-C, Wang C-J, Chang T-C, Wu C-R. Poria cocos Lanostane Triterpenoids Extract Promotes Collagen and Hyaluronic Acid Production in D-Galactose-Induced Aging Rats. Life. 2023; 13(11):2130. https://doi.org/10.3390/life13112130

Chicago/Turabian Style

Chao, Chien-Liang, Han-Peng Kuo, Hsin-Wen Huang, Maw-Yeun Cheng, Hsin-Fan Chao, Shih-Min Lu, Hang-Ching Lin, Chao-Jih Wang, Tsu-Chung Chang, and Chi-Rei Wu. 2023. "Poria cocos Lanostane Triterpenoids Extract Promotes Collagen and Hyaluronic Acid Production in D-Galactose-Induced Aging Rats" Life 13, no. 11: 2130. https://doi.org/10.3390/life13112130

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop